lapatinib has been researched along with epz-5676 in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (epz-5676) | Trials (epz-5676) | Recent Studies (post-2010) (epz-5676) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 37 | 1 | 37 |
| Protein | Taxonomy | lapatinib (IC50) | epz-5676 (IC50) |
|---|---|---|---|
| Histone-lysine N-methyltransferase, H3 lysine-79 specific | Homo sapiens (human) | 0.0119 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egbert, M; Keserű, GM; Vajda, S; Whitty, A | 1 |
1 other study(ies) available for lapatinib and epz-5676
| Article | Year |
|---|---|
Why Some Targets Benefit from beyond Rule of Five Drugs.
Topics: Binding Sites; Drug Discovery; Ligands; Molecular Weight; Protein Binding | 2019 |